Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05139745
Other study ID # BTL-899_CTUS400
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 11, 2021
Est. completion date August 11, 2022

Study information

Verified date August 2022
Source BTL Industries Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the safety and performance of the BTL-899 device for non-invasive treatment of subcutaneous fat. The changes in the fat tissue related to the activity of caspase-3 will be assessed histologically. The study is a prospective single-center single-blinded two-arm study. The subjects will be enrolled and assigned into two study groups; Group A which will receive active treatment and Group B which receives sham treatment and will serve as a control to verify the treatment outcomes. Subjects will be required to complete only one (1) treatment visit and three (3) follow-up visits (at 8 hours, 24 hours and 7 days post treatment). All of the study subjects will receive the treatment (either active or sham) with the subject device. At the baseline visit, health status will be assessed. Inclusion and exclusion criteria will be verified and informed consent will be signed. Punch biopsies from the treated abdominal area will be taken to examine the changes related to caspase-3 activity.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date August 11, 2022
Est. primary completion date April 27, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Age > 21 years - Voluntarily signed an informed consent form - BMI = 35 kg/m2 - Women of child-bearing potential are required to use birth control measures during the whole duration of the study. - Willingness to abstain from partaking in any treatments other than the study procedure - Willingness to comply with study instructions, to return to the clinic for the required visits and to undergo punch biopsies in the abdominal area. Exclusion Criteria: - Electronic implants (such as cardiac pacemakers, defibrillators, and neurostimulators) - Metal implants in the treated area - Drug pumps - Malignant tumor - Pulmonary insufficiency - Injured or otherwise impaired muscles in the treated area - Cardiovascular diseases - Disturbance of temperature or pain perception - Hemorrhagic conditions - Septic conditions and empyema - Acute inflammations in the treated area - Systemic or local infection such as osteomyelitis and tuberculosis - Contagious skin disease - Elevated body temperature - Application during pregnancy, postpartum period, nursing, and menstruation - Graves' disease - Skin related autoimmune diseases that may contradict the biopsy - Poor healing and unhealed wounds in the treatment area - Any disease or condition contradicting the skin tissue biopsy - Any disease or condition that may compromise the histologic observation at the pathologist discretion

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BTL-899
BTL-899 treatment

Locations

Country Name City State
United States Skin Laser and Surgery Specialist, a Division of Schweiger Dermatology Hackensack New Jersey

Sponsors (1)

Lead Sponsor Collaborator
BTL Industries Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increased caspase-3 activity Biopsy samples of the abdominal fat tissue will be processed for histological evaluation by a certified laboratory. Conventional staining will be used to determine the changes in the fat tissue related to the increase in caspase-3 activity, which is associated with elevated levels of fat tissue apoptosis, and to examine other morphological changes of treated tissue, in all collected samples. Post-treatment findings will be compared to the baseline. The results of both study groups will be compared as well. 1 month
Secondary Safety assessment Occurrence of adverse events 1 month
See also
  Status Clinical Trial Phase
Completed NCT04599257 - Fat Reduction and Muscle Toning of Thighs N/A
Completed NCT05580263 - Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. N/A
Completed NCT04643275 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms N/A
Completed NCT05975489 - Genetics in the Effect of Caffeine on Fat Oxidation N/A
Completed NCT04621019 - BTL-785F Device for Non-invasive Lipolysis and Circumference Reduction of the Abdomen N/A
Completed NCT04696614 - Testing the Effect of Exercise Intervention Using a SMART Design. N/A
Completed NCT04455009 - Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism N/A
Completed NCT05260164 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Flanks N/A
Recruiting NCT05261373 - Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 Diabetics N/A
Recruiting NCT04043182 - EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT N/A
Completed NCT04587804 - Abdomen - Fat Reduction and Muscle Toning N/A
Completed NCT05540080 - Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen N/A
Completed NCT04587986 - rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat N/A
Active, not recruiting NCT06274177 - Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation N/A
Completed NCT06282172 - Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue N/A
Not yet recruiting NCT03357601 - High Intensity Interval Training vs Moderate Continuous Endurance Exercise Training on Program Adherence N/A
Completed NCT05215275 - Comparison of Different Exercise Trainings on Heart Rate Variability N/A
Completed NCT03811093 - Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss N/A
Active, not recruiting NCT06333496 - Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans N/A
Not yet recruiting NCT06219850 - Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study